Mercer Global Advisors’s Ginkgo Bioworks DNA Stock Holding History

Mercer Global Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Buy	+15,506	New	+$130K	﹤0.01%	3328
2025 Q1	–	Sell	-11,836	Closed	-$116K	–	2181
2024 Q4	$116K	Buy	+11,836	New	+$101K	﹤0.01%	2022
2024 Q3	–	Sell	-1,375	Closed	-$18.4K	–	1977
2024 Q2	$18.4K	Sell	1,375 -2,796	-67%	-$83.4K	﹤0.01%	1951
2024 Q1	$194K	Buy	4,171 +703	+20%	+$36.4K	﹤0.01%	1792
2023 Q4	$234K	Sell	3,468 -2,076	-37%	-$127K	﹤0.01%	1751
2023 Q3	$401K	Buy	5,544 +3,042	+122%	+$243K	﹤0.01%	1363
2023 Q2	$186K	Buy	2,502 +2,122	+558%	+$126K	﹤0.01%	1751
2023 Q1	$20K	Sell	380 -77	-17%	-$4.88K	﹤0.01%	1898
2022 Q4	$31K	Buy	457 +145	+46%	+$13.3K	﹤0.01%	1889
2022 Q3	$39K	Buy	312 +58	+23%	+$6.91K	﹤0.01%	1781
2022 Q2	$24K	Buy	+254	New	+$31K	﹤0.01%	1793

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Mercer Global Advisors's DNA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 15,506 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #3328 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in DNA as recently as Q4 2024.

Mercer Global Advisors first reported a position in DNA in Q2 2022 and has held it in 11 quarters since. The position peaked at $401K in Q3 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Mercer Global Advisors held 15,506 shares of Ginkgo Bioworks worth $154K as of Q2 2026.
Ginkgo Bioworks was a new Mercer Global Advisors position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3328 holding.
Mercer Global Advisors first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 11 quarters since.
Mercer Global Advisors's Ginkgo Bioworks position peaked at $401K in Q3 2023.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.